Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STRENGTHENS: Study To Refine the Effectiveness of New Generation Therapies for Suicide

NCT07818889 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT07818889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07818889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STRENGTHENS: Study To Refine the Effectiveness of New Generation Therapies for Suicide
Lead sponsor
Ohio State University
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicide attempt, suicide risk, treatment response